Cobrotoxin suppresses TLR4-NF-κB/STAT1 signaling to mitigate glia-mediated neuroinflammation and motor deficits in Parkinson's disease
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.117322 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Chun-Ze Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 2…. Hauptthemen laut MEDLINE: Cobra Neurotoxin Proteins, Parkinson Disease, Neuroprotective Agents, Neuroinflammatory Diseases. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Priority Academic Program Development of Jiangsu Higher Education Institutions, Second Affiliated Hospital of Soochow University.
Abstract (Originalsprache)
Chronic neuroinflammation is implicated in the pathogenesis of Parkinson's disease (PD), contributing to progressive dopaminergic neuron loss. Cobrotoxin (CoTX), a short-chain α-neurotoxin isolated from Naja atra venom, exerts anti-inflammatory and analgesic effects in several inflammation-related disease models. However, whether CoTX modulates glia-mediated neuroinflammation or confers neuroprotection in PD remains unknown. In this study, we conducted a randomized, placebo-controlled clinical trial and preclinical animal studies to explore the therapeutic efficacy and mechanisms of CoTX in PD. A 12-day subcutaneous regimen of Cobratide (an injectable form of CoTX), consisting of 70 μg daily for 5 days, a 2-day interval, and another 5-day course, significantly improved motor symptoms in PD patients, as reflected by the UPDRS Part II + III scores, with a well-tolerated safety profile. These beneficial effects were further validated in both MPTP- and lipopolysaccharide-induced PD mouse models. Specifically, intranasal administration of CoTX ameliorated motor coordination defects, attenuated dopaminergic neuronal loss, and suppressed glia-mediated neuroinflammation in the substantia nigra of MPTP-challenged mice. Mechanistically, CoTX did not directly protect neurons; instead, it conferred indirect neuroprotection by inhibiting neuroinflammation via blockade of the NF-κB/STAT1 signaling cascades. Furthermore, CoTX functionally interacted with TLR4, which may act as a putative molecular target of CoTX. Collectively, these findings demonstrate the anti-neuroinflammatory and neuroprotective effects of CoTX in PD, highlighting its potential as a promising therapeutic candidate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China; Jiangsu Key Laboratory of Drug Discovery and Translation…
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
- Institute of Health Science and Technology, Gao Bo Institute of Vocational College, Suzhou, Jiangsu, 215163, China.
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China. Electronic address: lwfwxx@126.com.
- Department of Pharmacology, Laboratory of Aging and Nervous Diseases, Jiangsu Key Laboratory of Neuropsychiatric Diseases, Suzhou International Joint Laboratory for Diagnosis and Treatment of Brain Diseases, College of…
- Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China. Electronic address: nnliujing181@126.com.
Förderung
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Second Affiliated Hospital of Soochow University
Zitieren
APA
Yu, C. Z., Ma, S. Y., Cao, Y. C., Xu, D., Hou, X. O., Liu, C. F., Qin, Z. H., Luo, W. F., Wu, J. C., Liu, J., & Hu, L. F. (2026). Cobrotoxin suppresses TLR4-NF-κB/STAT1 signaling to mitigate glia-mediated neuroinflammation and motor deficits in Parkinson's disease. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117322
Vancouver
Yu CZ, Ma SY, Cao YC, Xu D, Hou XO, Liu CF, et al. Cobrotoxin suppresses TLR4-NF-κB/STAT1 signaling to mitigate glia-mediated neuroinflammation and motor deficits in Parkinson's disease. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117322
BibTeX
@article{Yu2026,
author = {Yu, Chun-Ze and Ma, Shu-Yang and Cao, Yu-Chen and Xu, Dan and Hou, Xiao-Ou and Liu, Chun-Feng and Qin, Zheng-Hong and Luo, Wei-Feng and Wu, Jun-Chao and Liu, Jing and Hu, Li-Fang},
title = {Cobrotoxin suppresses TLR4-NF-κB/STAT1 signaling to mitigate glia-mediated neuroinflammation and motor deficits in Parkinson's disease},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.117322}
}
EUVIMED